November 21, 2026

CHOLERA CALL Transparency in vaccine trail advised

The director general for health has advised the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) cholera experts to be 'transparent' in their vaccine trail.

bdnews24.com News Service

bdnews24.com

Published : 19 Jul 2011, 04:48 PM

Updated : 10 Aug 2022, 05:08 PM

Dhaka, July 19 (bdnews24.com) – The director general for health has advised the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) cholera experts to be 'transparent' in their vaccine trail. Khondaker Mohammed Shefyetullah told them to 'go forward in a transparent way' at a dissemination seminar in ICDDR,B on Tuesday where both the government and ICDDR,B tabled estimated figures of cholera patients in Bangladesh for the first time. The government had never reported cholera in over a decade, but an ICDDR,B vaccine trail in the capital made the government speak of cholera prevalence in the country at World Health Organisation's (WHO) meetings. A Bangladesh resolution was accepted by the May 16-24, 2011 World Health Assembly in Geneva. It is understood that ICDDR,B sponsored the government's delegation to Geneva to push forward the cholera issue. Experts raised eyebrows over the government stance on the water-borne disease and the ICDDR,B's feasibility study on oral cholera vaccine in the capital's Mirpur area with the titled 'Introduction of Oral Cholera Vaccine in Bangladesh'. Health rights activities earlier said the government had fallen 'into the trap of oral cholera vaccine'. Quoting the health minister, the director general said, "He (the minister) has told me to convey that the issue would be discussed further at a higher level." Health minister AFM Ruhal Haque, who was supposed to be there as the chief guest, failed to turn up due to a cabinet meeting. The director general said, "I am still in the dark about what is happening." "It's a very sensitive issue. Every detail of it should be discussed," he said, suggesting improved water, sanitation and personal hygiene. Prime Minister Office's director Baizid Khoorshid Riaz told the seminar that they won the 'cholera diplomacy.' However, he said, "We have to do many informal negotiations to press cholera issue in the WHO agenda." According to the ICDDR,B's cholera project paper, an estimated 12,00,000 people suffer from cholera in the country every year which is double the government's International Epidemiology Disease Control and Research (IEDCR) estimation of 400,000 people. IEDCR director Mahmudur Rahman said they had estimated the figure with the help of ICDDR'B scientists. ICDDR,B's principal investigator for cholera vaccine project Firdausi Qadri said their estimation included the number of infections – asymptomatic and mild ones. She, however, said 'sorry' for the project titled 'Introduction of Oral Cholera Vaccine in Bangladesh', as questions were raised at the seminar why the word 'introduction' was used when the vaccine is still in the study phase. "It was a misunderstanding, but that does not mean we have started cholera vaccine," she said, but could not say whether the project title would be changed. Qadri said they started the project during the tenure of the immediate past director general for health. ICDDR,B's consultant epidemiologist Dr A K Siddique said they (ICDDR,B) had reported to the government in the 1990s after a Rangpur outbreak. "But the government suppressed the information fearing slump in vegetables and shrimp trade," he said, "but things have been changed today." "Cholera is not that much fatal in Bangladesh as earlier because the bacterium has changed its strain and treatment is in place." ICDDR,B scientist Dr Stephen P Luby said apart from the cholera vaccine, "we also like to look at other strategies as only 23 percent of the people have cholera". "Washing hands with soap reduces 30-50 percent of diarrhea," he said, "It's (hand washing) the most cost effective way of prevention." Vaccine scientist Shahjahan Kabir in Sweden earlier told bdnews24.com that ICDDR,B had carried out a large-scale field trial of an oral cholera vaccine in Bangladesh in 1985. "Strong protests were launched in Bangladesh and Sweden on its validity as the trial did not follow ethical guidelines properly. "The vaccine had offered short-term protection and was practically ineffective in children, the group most vulnerable to cholera," he said in an email response. bdnews24.com/nih/nir/2240h
Related Stories